S&P/ASX 200 Index (ASX: XJO) shares are up 0.3% to 9,043.1 points on Tuesday.
Let's check out 3 shares with new ratings from the experts (courtesy The Bull).
Image source: Getty Images
Electro Optic Systems Holdings Ltd (ASX: EOS)
The Electro Optic Systems share price is $7.26, up 4.6% today and up 146% over 12 months.
Mark Gardner from MPC Markets has a buy rating on this ASX 200 industrials share.
Gardner explained:
This counter drone and laser weapons group had an order book of $846 million at June 30, 2026, an 84 per cent increase since December 31, 2025.
In May, it completed the acquisition of the MARSS Group, a provider of artificial intelligence enabled command and control systems for counter drone capability.
The company upgraded full year 2026 revenue guidance to between $280 million and $300 million, excluding MARRS.
The stock has fallen significantly between June 2 and July 30 to the point it has been materially over-sold, in our view.
Investors can consider buying EOS on weakness.
Xero Ltd (ASX: XRO)
The Xero share price is $73.53, up 3.1% today and down 58% over 12 months.
Gardner has a hold rating on this ASX 200 tech share, and commented:
Xero is a quality accounting software provider. The shares have plunged in the past 12 months, partly in response to investor concerns about artificial intelligence replacing some of its services.
The company has a credible product road map to meet the challenge, such as JAX-powered bank reconciliation and an integration with Microsoft 365 Copilot. The company recently surpassed 5 million subscribers.
Investors can hold, but should monitor the news flow.
Ramsay Health Care Ltd (ASX: RHC)
The Ramsay Health Care share price is $43.67, down 0.5% today and up 16% over 12 months.
Dylan Evans from Catapult Wealth has a sell rating on this ASX 200 healthcare share.
Evans said:
Ramsay owns and manages private hospitals in Australia, the UK and Europe.
The company benefits from an ageing population driving spending on health care. But cost of living and inflationary pressures contribute to higher labour costs for RHC. Also, stretched government budgets put pressure on health care spending.
Consequently, margins may be pressured over time as governments offer lower contributions and less than inflation levels of indexation.
The shares have risen from $34.59 on January 2 to trade at $44.04 on July 30.
Investors may want to consider cashing in some gains.
